个性化文献订阅>文章检索

文章名     作者     期刊名     摘要     卷     期         如果没有找到您所需要的文献，请点击 ——此处申请     共13条记录   What Is Value in Health Care?. [作者：Porter, ME,期刊：New England Journal of Medicine, 页码：2477-2481 , 文章类型： Editorial Material，,卷期：2010年363-26] Putting the Value Framework to Work. [作者：Lee, TH,期刊：New England Journal of Medicine, 页码：2481-2483 , 文章类型： Editorial Material，,卷期：2010年363-26] Courting Danger While Doing Good -- Protecting Global Health Workers from Harm. [作者：Panosian, C,期刊：New England Journal of Medicine, 页码：2484-2485 , 文章类型： Editorial Material，,卷期：2010年363-26] Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement. [作者：Lassen, MR; Gallus, A; Raskob, GE; Pineo, G; Chen, D; Ramirez, LM,期刊：New England Journal of Medicine, 页码：2487-2498 , 文章类型： Article，,卷期：2010年363-26] Background: There are various regimens for thromboprophylaxis after hip replacement. Low-molecular-weight heparins such as enoxaparin predominantly inhibit factor Xa but also inhibit thrombin to some degree. Orally activ... Oral Rivaroxaban for Symptomatic Venous Thromboembolism. [作者：Bauersachs, R; Berkowitz, SD; Brenner, B; Buller, HR; Decousus, H; Gallus, AS; Lensing, AW; Misselwitz, F; Prins, MH; Raskob, GE; Segers, A; Verhamme, P; Wells, P; Agnelli, G; Bounameaux, H; Cohen, A; Davidson, BL; Piovella, F; Schellong, S,期刊：New England Journal of Medicine, 页码：2499-2510 , 文章类型： Article，,卷期：2010年363-26] Background: Rivaroxaban, an oral factor Xa inhibitor, may provide a simple, fixed-dose regimen for treating acute deep-vein thrombosis (DVT) and for continued treatment, without the need for laboratory monitoring. Method... Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia. [作者：Preudhomme, C; Guilhot, J; Nicolini, FE; Guerci-Bresler, A; Rigal-Huguet, F; Maloisel, F; Coiteux, V; Gardembas, M; Berthou, C; Vekhoff, A; Rea, D; Jourdan, E; Allard, C; Delmer, A; Rousselot, P; Legros, L; Berger, M; Corm, S; Etienne, G; Roche-Lestienne, C; Eclache, V; Mahon, FX; Guilhot, F,期刊：New England Journal of Medicine, 页码：2511-2521 , 文章类型： Article，,卷期：2010年363-26] Background: Imatinib (400 mg daily) is considered the best initial therapy for patients with newly diagnosed chronic myeloid leukemia (CML) in the chronic phase. However, only a minority of patients treated with imatinib... Glycemic Control in the ICU. [作者：Kavanagh, BP; McCowen, KC,期刊：New England Journal of Medicine, 页码：2540-2546 , 文章类型： Article，,卷期：2010年363-26] Long-Term Mortality in Childhood-Onset Epilepsy. [作者：Sillanpaa, M; Shinnar, S,期刊：New England Journal of Medicine, 页码：2522-2529 , 文章类型： Article，,卷期：2010年363-26] Background: There are few studies on long-term mortality in prospectively followed, well-characterized cohorts of children with epilepsy. We report on long-term mortality in a Finnish cohort of subjects with a diagnosis ... Variability in the Measurement of Hospital-wide Mortality Rates. [作者：Shahian, DM; Wolf, RE; Iezzoni, LI; Kirle, L; Normand, SLT,期刊：New England Journal of Medicine, 页码：2530-2539 , 文章类型： Article，,卷期：2010年363-26] Background: Several countries use hospital-wide mortality rates to evaluate the quality of hospital care, although the usefulness of this metric has been questioned. Massachusetts policymakers recently requested an asses... Metastatic Pulmonary Calcification. [作者：Timmins, S; Hibbert, M,期刊：New England Journal of Medicine, 页码：2547-2547 , 文章类型： Editorial Material，,卷期：2010年363-26] Tinea. [作者：Lai-Cheong, J; McGrath, J,期刊：New England Journal of Medicine, 页码：E39-E39 , 文章类型： Editorial Material，,卷期：2010年363-26] Case 39-2010: A 19-Year-Old Woman with Nausea, Jaundice, and Pruritus. Severe panlobular hepatitis, with features that were consistent with the acute onset of autoimmune hepatitis. [作者：Friedman, LS; Gee, MS; Misdraji, J,期刊：New England Journal of Medicine, 页码：2548-2557 , 文章类型： Article，,卷期：2010年363-26] Therapeutic Potential of Oral Factor Xa Inhibitors. [作者：Hylek, EM,期刊：New England Journal of Medicine, 页码：2559-2561 , 文章类型： Editorial Material，,卷期：2010年363-26]